35 | MASIMO

Modern Healthcare - - HEALTHCARE’S HOTTEST -

WHAT IT DOES:

Pro­duces non­in­va­sive mon­i­tor­ing tech­nolo­gies that sig­nif­i­cantly im­prove pa­tient care. HOW IT GREW:

Masimo’s SET tech­nol­ogy, which of­fers the abil­ity to mon­i­tor dif­fer­ent el­e­ments of a pa­tient’s blood with­out in­va­sive surgery, has been mak­ing strides in the field of pulse oxime­try. In 2005, Masimo in­tro­duced the Rain­bow SET Pulse Co-Oxime­try tech­nol­ogy, and it has con­tin­ued to pro­duce in­no­va­tive tech­nolo­gies. Ac­cord­ing to a com­pany news re­lease, more than 100 in­de­pen­dent stud­ies have found that the SET tech­nol­ogy pro­vides the most re­li­able mea­sure­ments for pe­riph­eral oxy­gen sat­u­ra­tion and pulse-rates in the coun­try, which has re­duced false alarms and in­creased the de­tec­tion of life-threat­en­ing events.

A re­port pub­lished in the Lancet in July called pulse oxime­try a “new mile­stone” in the war on crit­i­cal con­gen­i­tal heart dis­ease. The meta-anal­y­sis pooled the re­sults of 13 stud­ies to con­clude that pulse oxime­try pro­vides a sig­nif­i­cant im­prove­ment over ex­ist­ing meth­ods in de­tect­ing ba­bies with crit­i­cal con­gen­i­tal heart dis­ease.

Newspapers in English

Newspapers from USA

© PressReader. All rights reserved.